Benchmarking of Outpatient Pediatric Antibiotic Prescribing: Results of a Multicenter Collaborative
Saturday, April 29, 2023
2:00 PM – 2:15 PM ET
Location: Convention Center: 146 A
Publication Number: 1480.1
Rana E. El Feghaly, Children's Mercy Kansas City, Kansas City, MO, United States; Joshua Herigon, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States; Bethany A. Wattles, University of Louisville School of Medicine, Louisville, KY, United States; Matthew Kronman, University of Washington School of Medicine, Seattle, WA, United States; Nicole Poole, University of Colorado School of Medicine, Aurora, CO, United States; Michael J. Smith, Duke University, Durham, NC, United States; Ana Vaughan, Boston Children's Hospital, Boston, MA, United States; Rosemary Olivero, Helen DeVos Children's Hospital, Grand Rapids, MI, United States; Sameer J. Patel, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States; Ann L.. Wirtz, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States; Zachary I. Willis, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States; Brian R. Lee, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States
Presenting Author(s)
Rana E. El Feghaly, MD, MSCI (she/her/hers)
Professor Children's Mercy Kansas City, UMKC Kansas City, Missouri, United States
Disclosure(s):
Rana E. El Feghaly, MD, MSCI: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Joshua Herigon, MD, MPH, MBI: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Bethany A. Wattles, PharmD, MHA: Merck (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)
Matthew Kronman, MD, MSCE: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Nicole Poole, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Michael J. Smith, MD, MSCE: Pfizer (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)
Ana Vaughan, MD, MPH: ARCTURUS THERAPEUTICS (Terminated, February 18, 2021) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); ASANA INC (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); AURORA CANNABIS INC (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); AYR WELLNESS (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); BIONANO GENOMICS (Terminated, February 18, 2021) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); BIONANO GENOMICS INC COM (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); BUTTERFLY NETWORK INC COM (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); CANOPY GROWTH CORP (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); CAREDX INC (Terminated, February 18, 2021) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); CRESCO LABS INC (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); CRISPR THERAPEUTICS AG COM (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); CRONOS GROUP INC (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); CURALEAF HOLDINGS INC (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); EDITAS MEDICINE INC COM (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); EXACT SCIENCES CORP (Terminated, February 18, 2021) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); FATE THERAPEUTICS (Terminated, February 18, 2021) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); GENETIC TECHNOLOGIES (Terminated, February 23, 2021) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); GOODRX HLDGS INC COM (Terminated, February 23, 2021) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); GREEN THUMB INDUSTRIES INC (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); HIGH TIDE INC (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); ILLUMINA INC COM (Terminated, March 4, 2021) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); INTELLIA THERAPEUTICS (Terminated, February 18, 2021) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); INVITAE CORP COM (Terminated, February 18, 2021) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); IOVANCE BIOTHERAPEUTICS INC COM (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); JUSHI HOLDINGS INC (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); MODERNA (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); ORGANIGRAM HOLDINGS INC (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); PACIFIC BIOSCIENCES OF CALIFORNIA INC (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); PERSONALIS INC COM (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); PFIZER INC (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); PROTO LABS INC COM (Terminated, February 19, 2021) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); SNDL INC (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); TELADOC HEALTH INC COM (Terminated, February 23, 2021) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); TERRASCEND CORP (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); TILRAY BRANDS INC (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); TRULIEVE CANNABIS CORP (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); TWIST BIOSCIENCE (Terminated, February 18, 2021) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)
Rosemary Olivero, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Sameer J. Patel, MD MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ann L. Wirtz, PharmD, BCPPS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Zachary I. Willis, MD, MPH: Merck Sharp & Dohme Corp (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Nabriva Therapeutics (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Novavax, Inc. (Terminated, June 30, 2022) (Products/Services: Research Support including clinical trials & the principal or named investigator); Pfizer Inc (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)
Brian R. Lee, PhD, MPH: Merck (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)
